Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosinter Restaurants Holding reported for 6 months of 2024 by RAS

7/31/24 ROST

Buryatzoloto reported for 6 months of 2024 by RAS

7/31/24 BRZL

RusHydro reported for 6 months of 2024 by RAS

7/31/24 HYDR

Chelyabinsk Metallurgical Plant will buy out Guryevsky Metallurgical Plant

7/31/24 MTLR

Chelyabinsk Metallurgical Plant will buy out Guryevsky Metallurgical Plant

7/31/24 CHMK

Mostotrest reported for 6 months of 2024 by RAS

7/31/24 MSTT

Severstal reported for 6 months of 2024 by RAS

7/31/24 CHMF

Super Lenta chain changes its design concept

7/31/24 LENT

Element creates serial production of power electronics

7/31/24 ELMT

Lukoil increased its network of charging stations by 1.7 times

7/31/24 LKOH